Engineers Gate Manager LP Stoke Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $4.86 Billion
- Q3 2024
A detailed history of Engineers Gate Manager LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 24,205 shares of STOK stock, worth $274,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,205
Previous 27,924
13.32%
Holding current value
$274,000
Previous $377,000
21.22%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding STOK
# of Institutions
124Shares Held
57.6MCall Options Held
9.3KPut Options Held
35.2K-
Skorpios Trust8.91MShares$101 Million99.85% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$61.2 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$58.7 Million22.82% of portfolio
-
Redmile Group, LLC San Francisco, CA4.71MShares$53.4 Million3.79% of portfolio
-
Rtw Investments, LP New York, NY4.65MShares$52.7 Million0.91% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $446M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...